EVOTEC SEINH O.N. news, videos and press releases
For more news please use our advanced search feature.
EVOTEC SEINH O.N. - More news...
EVOTEC SEINH O.N. - More news...
- EQS-News: Evotec announces change in Management Board
- Evotec Announces Change in Management Board
- EQS-News: Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
- Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
- EQS-News: Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
- Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
- EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
- Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
- EQS-News: Evotec SE reports first half-year 2024 results on 14 August 2024
- Evotec SE Reports First Half-year 2024 Results on 14 August 2024
- EQS-News: Evotec provides guidance update
- EQS-Adhoc: Evotec SE provides guidance update
- Evotec Provides Guidance Update
- Evotec SE Provides Guidance Update
- EQS-News: Evotec and Pfizer collaborate to advance drug discovery in France
- Evotec and Pfizer Collaborate to Advance Drug Discovery in France
- EQS-News: Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
- Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
- EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
- Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
- EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb
- Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
- EQS-News: Evotec SE: Results of the Annual General Meeting 2024
- Evotec SE: Results of the Annual General Meeting 2024
- EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
- Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
- EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
- Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
- EQS-News: Evotec reports Q1 2024 results and provides corporate update
- Evotec Reports Q1 2024 Results and Provides Corporate Update